Prevalence and Severity of Cramps in Chronic Kidney Disease Patients
CRAMéREIN
2 other identifiers
observational
250
1 country
1
Brief Summary
Cramps are a frequent and severe complication in CKD patients. Their characteristics : triggering factors, associated factors, are not well known. There is no recognized effective treatment. Using a questionnaire, the investigators wish to determine prevalence, severity and associated factors of cramps in our CKD patients. Better knowledge about cramps in CKD patients will allow to better support, and give a practical tool for treatment evaluation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2025
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 28, 2024
CompletedFirst Posted
Study publicly available on registry
December 17, 2024
CompletedStudy Start
First participant enrolled
January 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2025
CompletedDecember 17, 2024
December 1, 2024
6 months
November 28, 2024
December 11, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Prevalence of cramps in CKD III-V patients. Number of patients having cramps / number of questionned patients
Day 0 - visit of inclusion
Secondary Outcomes (6)
Measure of Severity of cramps
Day 0 - visit of inclusion
Frequency of pain intensity
Day 0 - visit of inclusion
Identification of potential triggering factors
Day 0 - visit of inclusion
Identification of associated factors (ionic desorders, medical treatment, degree of CKD, …)
Day 0 - visit of inclusion
Identification of potential improving treatment (medicinal or not)
Day 0 - visit of inclusion
- +1 more secondary outcomes
Study Arms (1)
Chronic Kidney Disease (CKD) Patients
Patients with CKD stade III to V (dialysis and non dialysis)
Eligibility Criteria
Every patient with Chronic Kidney Disease (non dialysis and dialysis patients)
You may qualify if:
- Voluntary patients with CKD III to V (GFR\<60ml/mn/1,72M2), including dialysed patients (hemodialysis or peritoneal dialysis).
- Non opposed to participate to the research.
You may not qualify if:
- Transplanted patient with functional graft.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hôpital Pitié Salpêtrière Service de néphrologie
Paris, 75013, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Marie-Alyette Costa de Beauregard, MD
Assistance Publique - Hôpitaux de Paris
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 28, 2024
First Posted
December 17, 2024
Study Start
January 1, 2025
Primary Completion
July 1, 2025
Study Completion
July 1, 2025
Last Updated
December 17, 2024
Record last verified: 2024-12
Data Sharing
- IPD Sharing
- Will not share